336 related articles for article (PubMed ID: 11847596)
1. Cardiopulmonary bypass copolymer surface modification reduces neither blood loss nor transfusions in coronary artery surgery.
Südkamp M; Mehlhorn U; Reza Raji M; Hekmat K; Easo J; Geissler HJ; Sindhu D; de Vivie R
Thorac Cardiovasc Surg; 2002 Feb; 50(1):5-10. PubMed ID: 11847596
[TBL] [Abstract][Full Text] [Related]
2. Impact of hematocrit value after coronary artery surgery on perioperative myocardial infarction rate.
Klass O; Mehlhorn U; Zilkens K; Kröner A; Hekmat K; Geissler HJ; de Vivie ER
Thorac Cardiovasc Surg; 2002 Oct; 50(5):259-65. PubMed ID: 12375180
[TBL] [Abstract][Full Text] [Related]
3. Hyperbaric oxygen preconditioning improves myocardial function, reduces length of intensive care stay, and limits complications post coronary artery bypass graft surgery.
Yogaratnam JZ; Laden G; Guvendik L; Cowen M; Cale A; Griffin S
Cardiovasc Revasc Med; 2010; 11(1):8-19. PubMed ID: 20129356
[TBL] [Abstract][Full Text] [Related]
4. Effects of methylprednisolone and a biocompatible copolymer circuit on blood activation during cardiopulmonary bypass.
Rubens FD; Nathan H; Labow R; Williams KS; Wozny D; Karsh J; Ruel M; Mesana T
Ann Thorac Surg; 2005 Feb; 79(2):655-65. PubMed ID: 15680854
[TBL] [Abstract][Full Text] [Related]
5. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C
J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955
[TBL] [Abstract][Full Text] [Related]
6. The impact of allogenic red cell transfusion and coated bypass circuit on the inflammatory response during cardiopulmonary bypass: a randomized study.
Senay S; Toraman F; Gunaydin S; Kilercik M; Karabulut H; Alhan C
Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):93-9. PubMed ID: 18801802
[TBL] [Abstract][Full Text] [Related]
7. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial.
Niranjan G; Asimakopoulos G; Karagounis A; Cockerill G; Thompson M; Chandrasekaran V
Eur J Cardiothorac Surg; 2006 Aug; 30(2):271-7. PubMed ID: 16829083
[TBL] [Abstract][Full Text] [Related]
8. Cardiopulmonary bypass copolymer surface modification reduces neither blood loss nor transfusions in coronary artery surgery.
Rubens F; Nathan H
Thorac Cardiovasc Surg; 2002 Dec; 50(6):384. PubMed ID: 12457322
[No Abstract] [Full Text] [Related]
9. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
Gersak B; Sutlic Z
Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
[TBL] [Abstract][Full Text] [Related]
10. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
[TBL] [Abstract][Full Text] [Related]
11. Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery.
Oliver WC; Nuttall GA; Ereth MH; Santrach PJ; Buda DA; Schaff HV
J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):165-70. PubMed ID: 12698396
[TBL] [Abstract][Full Text] [Related]
12. Miniaturized versus conventional cardiopulmonary bypass in high-risk patients undergoing coronary artery bypass surgery.
Koivisto SP; Wistbacka JO; Rimpiläinen R; Nissinen J; Loponen P; Teittinen K; Biancari F
Perfusion; 2010 Mar; 25(2):65-70. PubMed ID: 20179173
[TBL] [Abstract][Full Text] [Related]
13. Miniaturized cardiopulmonary bypass and acute kidney injury in coronary artery bypass graft surgery.
Benedetto U; Luciani R; Goracci M; Capuano F; Refice S; Angeloni E; Roscitano A; Sinatra R
Ann Thorac Surg; 2009 Aug; 88(2):529-35. PubMed ID: 19632407
[TBL] [Abstract][Full Text] [Related]
14. The use of minimized extracorporeal circulation system has a beneficial effect on hemostasis--a randomized clinical study.
Abdel-Rahman U; Martens S; Risteski P; Ozaslan F; Riaz M; Moritz A; Wimmer-Greinecker G
Heart Surg Forum; 2006; 9(1):E543-8. PubMed ID: 16403712
[TBL] [Abstract][Full Text] [Related]
15. Coronary artery bypass grafting with a minimized cardiopulmonary bypass circuit: a prospective, randomized trial.
Sakwa MP; Emery RW; Shannon FL; Altshuler JM; Mitchell D; Zwada D; Holter AR
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):481-5. PubMed ID: 19185173
[TBL] [Abstract][Full Text] [Related]
16. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass.
Andreasen JJ; Nielsen C
Eur J Cardiothorac Surg; 2004 Aug; 26(2):311-7. PubMed ID: 15296889
[TBL] [Abstract][Full Text] [Related]
18. Pulsatile perfusion with intra-aortic balloon pumping ameliorates whole body response to cardiopulmonary bypass in the elderly.
Onorati F; Santarpino G; Presta P; Caroleo S; Abdalla K; Santangelo E; Gulletta E; Fuiano G; Costanzo FS; Renzulli A
Crit Care Med; 2009 Mar; 37(3):902-11. PubMed ID: 19237895
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for prolonged ICU stay in patients following coronary artery bypass grafting with a long duration of cardiopulmonary bypass.
Nakasuji M; Matsushita M; Asada A
J Anesth; 2005; 19(2):118-23. PubMed ID: 15875128
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylcholine-coated circuits improve preservation of platelet count and reduce expression of proinflammatory cytokines in CABG: a prospective randomized trial.
Schulze CJ; Han L; Ghorpade N; Etches WS; Stang L; Koshal A; Wang SH
J Card Surg; 2009; 24(4):363-8. PubMed ID: 19583605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
